Targeting metabotropic glutamate receptor 4 for cancer immunotherapy.
Wan Z, Sun R, Liu YW, Li S, Sun J, Li J, Zhu J, Moharil P, Zhang B, Ren P, Ren G, Zhang M, Ma X, Dai S, Yang D, Lu B, Li S.
Wan Z, et al.
Sci Adv. 2021 Dec 10;7(50):eabj4226. doi: 10.1126/sciadv.abj4226. Epub 2021 Dec 10.
Sci Adv. 2021.
PMID: 34890233
Free PMC article.